COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1491: Articles 14901-14910  | Next

Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Harrington, P., de Lavallade, H., Doores, K., O'Reilly, A., Seow, J., Graham, C., Lechmere, T., Radia, D., Dillon, R., Shanmugharaj, Y., Espehana, A., Woodley, C., Saunders, J., Curto Garcia, N., O'Sullivan, J., Raj, K., Kordasti, S., Malim, M. H., Harrison, C. N., McLornan, D.
10.1101/2021.04.27.21256096 — Posted: 2021-05-11
SARS-CoV-2 infection induces autoimmune antibody secretion more in lean than in obese COVID-19 patients
Frasca, D., Reidy, L., Romero, M., Diaz, A., Cray, C., Kahl, K., Blomberg, B.
10.1101/2021.05.05.21256686 — Posted: 2021-05-11
Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases
Taquet, M., Husain, M., Geddes, J. R., Luciano, S., Harrison, P.
10.1101/2021.04.27.21256153 — Posted: 2021-05-11 Discussion: Onsite
SARS-CoV-2 receptor ACE2 identifies immuno-hot tumors in breast cancer
Mei, J., Cai, Y., Xu, R., Yu, X., Chen, L., Ma, T., Gao, T., Gao, F., Zhu, Y., Zhang, Y.
10.1101/2021.05.10.443377 — Posted: 2021-05-10
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Edara, V.-V., Lai, L., Sahoo, M., Floyd, K., Sibai, M., Solis, D., Flowers, M. W., Hussaini, L., Ciric, C. R., Bechnack, S., Stephens, K., Mokhtari, E. B., Mudvari, P., Creanga, A., Pegu, A., Derrien-Colemyn, A., Henry, A. R., Gagne, M., Graham, B. S., Wrammert, J., Douek, D. C., Bortiz, E., Pinsky, B. A., Suthar, M.
10.1101/2021.05.09.443299 — Posted: 2021-05-10
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Pinto, D., Sauer, M. M., Czudnochowski, N., Low, J. S., Tortorici, M. A., Housley, M. P., Noack, J., Walls, A. C., Bowen, J. E., Guarino, B., Rosen, L. E., di Iulio, J., Jerak, J., Kaiser, H., Islam, S., Jaconi, S., Sprugasci, N., Culap, K., Abdelnabi, R., Foo, C. S.-Y., Coelmont, L., Bartha, I., Bianchi, S., Silacci-Fregni, C., Bassi, J., Marzi, R., Vetti, E., Cassotta, A., Ceschi, A., Ferrari, P., Cippa', P. E., Giannini, O., Ceruti, S., Riva, A., Benigni, F., Cameroni, E., Piccoli, L., Pizzuto, M. S., Smithey, M., Hong, D., Telenti, A., Lempp, F. A., Neyts, J., Havenar-Daughton, C., Lanzave
10.1101/2021.05.09.442808 — Posted: 2021-05-10
Convergent use of phosphatidic acid for Hepatitis C virus and SARS-CoV-2 replication organelle formation
Tabata, K., Prasad, V., Paul, D., Lee, J.-Y., Pham, M.-T., Twu, W.-I., Neufeldt, C. J., Cortese, M., Cerikan, B., Tran, C. S., Luechtenborg, C., Vkovski, P., Hoermann, K., Mueller, A., Zitzmann, C., Haselmann, U., Beneke, J., Kaderali, L., Erfle, H., Thiel, V., Lohmann, V., Superti-Furga, G., Bruegger, B., Bartenschlager, R.
10.1101/2021.05.10.443480 — Posted: 2021-05-10
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Dickey, T. H., Tang, W. K., Butler, B., Ouahes, T., Orr-Gonzalez, S., Salinas, N. D., Lambert, L. E., Tolia, N. H.
10.1101/2021.05.09.443238 — Posted: 2021-05-10
Following the Trail of One Million Genomes: Footprints of SARS-CoV-2 Adaptation to Humans
Akther, S., Bezrucenkovas, E., Li, L., Sulkow, B., Di, L., Pante, D., Martin, C. L., Luft, B. J., Qiu, W.
10.1101/2021.05.07.443114 — Posted: 2021-05-10
In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrum
Espinosa, L. A., Ramos, Y., Andujar, I., Torres, E. O., Cabrera, G., Martin, A., Gonzalez, D., Chinea, G., Becquet, M., Gonzalez, I., Canaan-Haden, C., Nelson, E., Rojas, G., Perez-Masson, B., Perez-Martinez, D., Boggiano, T., Palacio, J., Lozada-Chang, S. L., Hernandez, L., de la Luz, K. R., Markku, S., Marika, V., Valdes-Balbin, Y., Santana-Medero, D., G. Rivera, D., Verez Bencomo, V., Emalfarb, M., Tchelet, R., Guillen, G., Limonta, M., Pimentel, E., Ayala, M., Besada, V., Gonzalez, L. J.
10.1101/2021.05.10.443404 — Posted: 2021-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).